TP53 and neoplasm: Consistent with the ASNase data (Fig. 4h and Supplementary Fig. 7e, f), the knockdown of ASNS in multiple tumour cell lines substantially increased G1 arrest in wildtype p53-expressing cells but not in p53-depleted cells.